“…Muscle defects and degenerative diseases affect the lives and quality of life of many patients worldwide.The administration of the drug is ine cient at regenerating damaged tissue, and the toxicity of the drug is a major blow to the patient's body.Stem cell therapy is considered a good way to repair lost cells [12].Mesenchymal stem cells (MSCs) have the ability of self-renewal, multidirectional differentiation and immune regulation, and they are the most ideal candidate cells in cell therapy and regenerative medicine [12]. MSCs are derived from many tissues including bone marrow [16], lung [17], fat [18], liver [19], umbilical cord [20], amniotic uid [21], placenta [22]and umbilical cord blood [23].It has been reported that these cells have the potential to differentiate into skeletal muscle [24], cardiomyocytes [25] and smooth muscle cells [26].Among cells of various sources, ADSCs are stem cells that have been repeatedly reported and clearly possess myogenic differentiation potential, and can differentiate into muscle tissue under the action of various induction products such as 5-aza, boron and cyclic uniaxial stress [27].Among the several products studied, 5-aza has been shown to be a suitable inducer with stable inductivity, despite the wide variety of products studied.5-aza is a cytidine like DNA methylation inhibitor which was known to promote up-regulation of muscle genes and differentiation of hMSC [27].Previous studies have shown that it can alter cell fate and differentiate MSCs into cardiomyocytes through a speci c molecular mechanism involving DNA demethylation and histone a key step in cell epigenetic modi cation [28]. However, due to the toxic effect of 5-aza, cell viability is limited and myoblast differentiation e ciency is not high.…”